United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The US was already grappling with spiraling healthcare expenditure, lack of affordable care, astronomical drug prices, and a high number of uninsured individuals before the devastating COVID-19 pandemic hit, leaving the healthcare system decimated. Later in the year, the US presidential election added another layer of complexity and division, with the candidates battling over many healthcare issues.

Scope

This report reviews some of the most important events that occurred in the drug pricing and reimbursement landscape in the US in 2020. This includes initiatives by the Trump Administration, including executive orders related to drug pricing, the Medicare Part D Senior Savings Model for insulin, and the expansion of telehealth services beyond the pandemic. It also assesses the impact of the COVID-19 pandemic on health insurance coverage and premium rates, and looks at the key battlegrounds during the US Election.

As the US now has a new President with different healthcare agendas and priorities, as well as the power to overturn many of the Trump Administration’s policies, considerations for the 2021 drug pricing and reimbursement landscape have also been included.

Reasons to Buy

Get an overview of Trump Administration drug pricing policies, including the Medicare Part D Senior Savings Model for insulin. See the status of executive orders issued by the Administration in 2020, including any ongoing lawsuits.

Understand how the COVID-19 pandemic impacted insurance coverage, insurance rates, and access to telemedicine in the US in 2020.

Understand the key healthcare battlegrounds during the US Presidential Election in 2020.

Get an assessment of the potential impact of the Trump Administration drug pricing policies in 2021 and beyond.

See how President Biden can shape the US drug pricing and reimbursement landscape in the US, particularly in areas such as the Affordable Care Act.

Table of Contents

Executive Summary

US Drug Pricing Landscape 2020

– Trump Administration Drug Pricing Policies

– Medicare Part D Senior Savings Model for Insulin

– Lowering Drug Prices by Putting America First

– Access to Affordable Life-Saving Medications

– Lowering Prices for Patients by Eliminating Kickbacks to Middlemen

– Increasing Drug Importation to Lower Prices for American Patients

– Drug Pricing and Gouging Continued Across the Industry in 2020

– Drug Pricing Influencer

COVID-19

– Impact of COVID-19 on Insurance Coverage

– Loss of Employer-Sponsored Insurance Coverage During the Pandemic

– Expansion of the Affordable Care Act to Lower the Number of Uninsured Individuals

– Impact of COVID-19 on Insurance Premiums

– Increased Access to Telemedicine During the Pandemic

– Telemedicine Before the COVID-19 Pandemic

– Changes to Telemedicine Reimbursement Policies During the COVID-19 Pandemic

– Increased Use of Telemedicine Due to COVID-19

– Access to Telemedicine in the US After COVID-19

Impact of the 2020 US Presidential Election

– The Affordable Care Act

– Drug Pricing Policy

Considerations for 2021

– Drug Pricing and Reimbursement Constraints Expected to Impede Industry Growth in 2021

– The Trump Administration’s Reforms Will Have Minimal Impact on the Drug Pricing Landscape in 2021

– Strengthening the ACA Will Be Important in Reducing the High Number of Uninsured Individuals in the US

– The Impact of COVID-19 on Insurance Premiums Will Not Be Fully Known Until Later in 2021

– The Future of US Telehealth Looks Promising Under the Biden Administration

Appendix

– Abbreviations

– Related Reports

– Bibliography

– About the Authors

– About GlobalData

– Contact Us

Frequently asked questions

United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research thematic reports
Currency USD
$695

Can be used by individual purchaser only

$1,495

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research in real time.

  • Access a live United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.